APA (7th ed.) Citation

A, J., X, L., S, H., W, J. L., H, Y., A, T., . . . DG, T. (2026). Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02700-w

Chicago Style (17th ed.) Citation

A, Jamroze, et al. "Single-cell Imaging Analysis, Therapeutic Modeling and a Phase Ib Trial Validate BCL-2 as a Target Across Heterogeneous Castration-resistant Prostate Cancer." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02700-w.

MLA (9th ed.) Citation

A, Jamroze, et al. "Single-cell Imaging Analysis, Therapeutic Modeling and a Phase Ib Trial Validate BCL-2 as a Target Across Heterogeneous Castration-resistant Prostate Cancer." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02700-w.